-
41.发明授权Circuit arrangement for deriving a signal indicating noise in a received stereo multiplex signal 失效用于导出指示接收的立体声多路复用信号中的噪声的信号的电路装置
公开(公告)号：US5606619A
公开(公告)日：1997-02-25
申请号：US343416
申请日：1995-02-13
Applicant: Djahanyar Chahabadi , Matthias Herrmann , Lothar Vogt , Juergen Kaesser
Inventor： Djahanyar Chahabadi , Matthias Herrmann , Lothar Vogt , Juergen Kaesser
CPC classification number: H04B1/1661 , H04B1/1027
Abstract: A circuit arrangement for deriving the signal indicating noise in a received stereo multiplex signal, wherein the stereo multiplex signal is present as a digital signal with a first sampling rate that is substantially higher than twice the upper limit of the useful frequency range of the stereo multiplex signal, and the received stereo multiplex signal is passed through a low-pass filter. The low-pass filtered signal and the received stereo multiplex signal are subjected to decimation to a second sampling rate, which is higher than twice the upper limit of the useful frequency range of the stereo multiplex signal. The two stereo multiplex signals with the second sampling rate are subtracted from one another.
Abstract translation: PCT No.PCT / DE94 / 00322 Sec。 371日期1995年2月13日 102（e）日期1995年2月13日PCT 1994年3月22日PCT公布。 公开号WO94 / 22230 日期1994年9月29日一种用于导出在接收的立体声多路复用信号中指示噪声的信号的电路装置，其中立体声多路复用信号作为数字信号存在，其具有明显高于有用频率上限的两倍的第一采样率 立体声多路复用信号的范围和接收的立体声多路复用信号通过低通滤波器。 低通滤波信号和接收的立体声多路复用信号被抽取到高于立体声多路复用信号的有用频率范围的两倍的第二采样率。 具有第二采样率的两个立体声多路复用信号彼此相减。
-
公开(公告)号：US5592557A
公开(公告)日：1997-01-07
申请号：US343414
申请日：1995-02-16
Applicant: Djahanyar Chahabadi , Matthias Herrmann , Lothar Vogt , Juergen Kaesser
Inventor： Djahanyar Chahabadi , Matthias Herrmann , Lothar Vogt , Juergen Kaesser
CPC classification number: H04B1/1661 , H04B1/1027
Abstract: In a radio receiver with digital signal processing, a stereo multiplex signal received and the useful signals derived therefrom are processed in digital form at a first sampling rate. The subsidiary signals derived from the stereo multiplex signal are at least partly processed at a second sampling rate that is smaller than the first sampling rate. The sampling rate of the processed subsidiary signals are reduced to the first sampling rate with the processed subsidiary signals, acting as control signals with the first sampling rate, affecting the stereo multiplex signal and the useful signals.
Abstract translation: PCT No.PCT / DE94 / 00326 Sec。 371日期1995年2月16日 102（e）日期1995年2月16日PCT 1994年3月22日PCT公布。 出版物WO94 / 22232 日期1994年9月29日在具有数字信号处理的无线电接收机中，接收的立体声多路复用信号和从其导出的有用信号以数字形式以第一采样率进行处理。 从立体声多路复用信号导出的辅助信号至少部分地以小于第一采样率的第二采样率进行处理。 处理的辅助信号的采样率被降低到第一采样率，其中处理的辅助信号用作具有第一采样率的控制信号，影响立体声多路复用信号和有用信号。
-
43.发明授权
公开(公告)号：US5280352A
公开(公告)日：1994-01-18
申请号：US817186
申请日：1992-01-06
Applicant: Matthias Herrmann
Inventor： Matthias Herrmann
CPC classification number: H04N5/956
Abstract: A digital circuit arrangement for transforming an input digital picture signal onto a reference horizontal synchronizing signal raster derived from the system clock, which input digital picture signal is present at a system clock rate not locked with the input digital picture signal, which includes a correction memory (1), an interpolator/decimator (2), and a control member for the purpose of a transformation which is as insensitive to interference as possible. The control member receives a control deviation signal (d) obtained with the aid of a discriminator (4) by comparing a horizontal synchronizing signal in the input digital picture signal with the reference horizontal synchronizing signal, and the control member applies a first correcting variable (i) to the correction memory (1), the first correcting variable (i) indicating transformation of the input digital picture signal by integral multiples of the system clock period to be performed by the correction memory (1), and the control member also applies a second correcting variable (.alpha..sub.s) to the interpolator/decimator (2), the second correcting variable (.alpha..sub.s) indicating the transformation by fractions of the system clock period to be performed by the interpolator/decimator (2).
Abstract translation: 对于数字电路装置，用于将具有未与其耦合的系统定时存在的数字图像信号变换为从系统定时导出的参考水平同步信号模式，其中具有校正存储器（1）和内插器/ 抽取器（2），为可能的噪声不敏感变换提供控制器，该控制器被提供有通过将数字图像信号中包含的水平信号和参考水平信号进行比较而获得的控制误差信号（d） 鉴别器（4），并且控制器向校正存储器（1）提供第一致动变量（i），该第一致动变量（i）指定由该存储器执行的数字图像信号的变换，以系统定时周期的整数倍;以及 提供给内插器/抽取器（2）第二致动变量（α），其指定要由该内插器/抽取器由分数进行的变换 系统定时周期。
-
44.发明授权Digital circuit arrangement for processing an analog video signal at a free running system clock 失效用于在自由运行系统时钟处理模拟视频信号的数字电路装置
公开(公告)号：US5121207A
公开(公告)日：1992-06-09
申请号：US599336
申请日：1990-10-17
Applicant: Matthias Herrmann
Inventor： Matthias Herrmann
CPC classification number: H04N5/0736 , H04N9/896
Abstract: In a digital circuit arrangement for processing an analog video signal, which operates at a fixed system clock not coupled to the video signal, in which the video signal is sampled and which comprises a correction memory (4) and an interpolator with decimator (14) which are used for converting the digital video signal to a synchronizing signal raster predetermined by the system clock, there is provided that the correction memory (4) has a predetermined number of memory sections (5, 6, 7, 8) arranged for storing each the sample values of one picture line which sample values are written or read out at the system clock, that each horizontal synchronizing pulse of the still unconverted video signal triggers a writing process of the subsequent picture line into a memory section (5, 6, 7, 8) and that each horizontal synchronizing pulse derived from the system clock triggers a reading process of the picture line that follows the previously read picture line.
Abstract translation: 在用于处理视频信号被采样并且包括校正存储器（4）和具有抽取器（14）的内插器的视频信号未被耦合的固定系统时钟的模拟视频信号的数字电路装置中， 其被用于将数字视频信号转换为由系统时钟预定的同步信号光栅，其特征在于，所述校正存储器（4）具有预定数量的存储器部分（5,6,7,8） 在系统时钟处写入或读出采样值的一个图像行的样本值，仍未转换的视频信号的每个水平同步脉冲触发后续图像行的写入处理到存储器部分（5,6,7） ，8），并且从系统时钟导出的每个水平同步脉冲触发先前读取的图像行之后的图像行的读取处理。
-
45.发明授权Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments 有权作为PAR1抑制剂的三唑鎓盐，其制备和用作药物公开(公告)号：US08853206B2
公开(公告)日：2014-10-07
申请号：US13452146
申请日：2012-04-20
Applicant: Uwe Heinelt , Volkmar Wehner , Matthias Herrmann , Karl Schoenafinger , Henning Steinhagen
Inventor： Uwe Heinelt , Volkmar Wehner , Matthias Herrmann , Karl Schoenafinger , Henning Steinhagen
IPC: C07D249/00 , C07D413/06 , C07D487/04 , C07D471/04 , A61P7/00
CPC classification number: C07D487/04 , C07D471/04
Abstract: The invention relates to novel compounds of formula I where X, A−, Q1, Q2, Q3, R2, R3, R4, R5, R6, R7, R8 and R9 are each as defined below. The compounds of formula I have antithrombotic activity and inhibit especially protease-activated receptor 1 (PAR1). The invention further relates to a process for preparing the compound of formula I and to the use thereof as a medicament.
Abstract translation: 本发明涉及式I的新化合物，其中X，A，Q 1，Q 2，Q 3，R 2，R 3，R 4，R 5，R 6，R 7，R 8和R 9各自定义如下。 式I的化合物具有抗血栓形成活性并特别抑制蛋白酶活化的受体1（PAR1）。 本发明还涉及制备式I化合物及其作为药物的用途的方法。
-
Patent Agency Ranking
46.发明授权Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments 有权作为PAR1抑制剂的三唑鎓盐，其制备和用作药物公开(公告)号：US08198272B2
公开(公告)日：2012-06-12
申请号：US12851219
申请日：2010-08-05
Applicant: Uwe Heinelt , Volkmar Wehner , Matthias Herrmann , Karl Schoenafinger , Henning Steinhagen
Inventor： Uwe Heinelt , Volkmar Wehner , Matthias Herrmann , Karl Schoenafinger , Henning Steinhagen
IPC: C07D487/04 , C07D413/10 , A61K31/5025 , A61K31/5355 , A61P7/00 , A61P9/10 , A61P29/00 , A61P37/08 , A61P3/14
CPC classification number: C07D487/04 , C07D471/04
Abstract: The invention relates to novel compounds of formula I where X, A−, Q1, Q2, Q3, R2, R3, R4, R5, R6, R7, R8 and R9 are each as defined below. The compounds of formula I have antithrombotic activity and inhibit especially protease-activated receptor 1 (PAR1). The invention further relates to a process for preparing the compound of formula I and to the use thereof as a medicament.
Abstract translation: 本发明涉及式I的新化合物，其中X，A，Q 1，Q 2，Q 3，R 2，R 3，R 4，R 5，R 6，R 7，R 8和R 9各自定义如下。 式I的化合物具有抗血栓形成活性并特别抑制蛋白酶活化的受体1（PAR1）。 本发明还涉及制备式I化合物及其作为药物的用途的方法。
-
47.发明授权EGLN2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart disease 失效EGLN2变体及其在预防或治疗血栓栓塞性疾病和冠心病中的用途公开(公告)号：US08114398B2
公开(公告)日：2012-02-14
申请号：US12089627
申请日：2006-09-30
Applicant: Detlef Kozian , Matthias Herrmann
Inventor： Detlef Kozian , Matthias Herrmann
CPC classification number: C12N9/0071
Abstract: The present invention refers to human EGLN2 variants having at position 58 of the amino acid sequence a serine or a leucine and their use in the prevention or treatment of thromboembolic or coronary heart diseases, in particular stroke, prolonged reversible ischemic neurological deficit (PRIND), transitoric ischemic attack (TIA), myocardial infarction and/or early myocardial infarction.
Abstract translation: 本发明涉及具有丝氨酸或亮氨酸的氨基酸序列58位的人EGLN2变异体及其在预防或治疗血栓栓塞或冠心病，特别是中风，长期可逆性缺血性神经功能缺损（PRIND）， 经皮缺血发作（TIA），心肌梗死和/或早期心肌梗死。
-
公开(公告)号：US08084198B2
公开(公告)日：2011-12-27
申请号：US11913873
申请日：2006-05-03
Applicant: Detlef Kozian , Matthias Herrmann , Karl-Ernst Siegler , Jean-Francois Deleuze , Sylvain Ricard , Sandrine Mace
Inventor： Detlef Kozian , Matthias Herrmann , Karl-Ernst Siegler , Jean-Francois Deleuze , Sylvain Ricard , Sandrine Mace
CPC classification number: C12Q1/6883 , C12Q1/6897 , C12Q2600/156 , C12Q2600/158
Abstract: The use of the single nucleotide polymorphism (SNP) at position −(97) of the GIP gene for the identification of a cardiovascular disease or of an increased risk for developing a cardiovascular disease in a biological sample taken from an individual to be examined.
Abstract translation: 在GIP基因的位置（97）处使用单核苷酸多态性（SNP）来鉴定从被检查个体获取的生物样品中的心血管疾病或发展心血管疾病的风险增加。
-
49.发明申请IMIDAZOPYRIDAZINES AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE AS MEDICAMENTS 有权咪达唑啶作为PAR1抑制剂，其生产和用作药物公开(公告)号：US20110034456A1
公开(公告)日：2011-02-10
申请号：US12851198
申请日：2010-08-05
Applicant: Uwe HEINELT , Volkmar WEHNER , Matthias HERRMANN , Karl SCHOENAFINGER , Henning STEINHAGEN
Inventor： Uwe HEINELT , Volkmar WEHNER , Matthias HERRMANN , Karl SCHOENAFINGER , Henning STEINHAGEN
IPC: A61K31/5377 , C07D487/04 , A61K31/5025 , A61P9/10 , A61P9/00 , A61P7/02 , A61P29/00 , A61P3/10 , A61P35/00 , A61P35/04 , A61P19/02 , A61P11/00 , A61P3/00 , A61P9/06
CPC classification number: C07D487/04
Abstract: The invention relates to novel compounds of formula I where R1, R2, R3, R4, R5, R6, R7, R8, R9, Q1, Q2 and Q3 are each as defined below. The compounds of formula I have antithrombotic activity and inhibit especially protease-activated receptor 1 (PAR1). The invention further relates to a process for preparing the compound of formula I and to the use thereof as a medicament.
Abstract translation: 本发明涉及新的式I化合物，其中R1，R2，R3，R4，R5，R6，R7，R8，R9，Q1，Q2和Q3各自如下所定义。 式I的化合物具有抗血栓形成活性并特别抑制蛋白酶活化的受体1（PAR1）。 本发明还涉及制备式I化合物及其作为药物的用途的方法。
-
50.发明申请USE OF CLEC1B FOR THE DETERMINATION OF CARDIOVASCULAR AND THROMBOTIC RISK 审中-公开CLEC1B用于确定心血管和血栓风险的应用公开(公告)号：US20100311053A1
公开(公告)日：2010-12-09
申请号：US12679547
申请日：2008-09-13
Applicant: Detlef Kozian , Peter Wonerow , Matthias Herrmann
Inventor： Detlef Kozian , Peter Wonerow , Matthias Herrmann
CPC classification number: G01N33/566 , C12Q1/6883 , C12Q2600/106 , C12Q2600/136 , C12Q2600/156 , G01N2333/7056 , G01N2500/04 , G01N2800/32 , G01N2800/50 , G01N2800/52
Abstract: The use of the single nucleotide polymorphism (SNP) of the CLEC1B gene for the identification of cardiovascular and/or thrombotic disorders or of an increased risk for developing cardiovascular and/or thrombotic disorders in a biological sample taken from an individual to be examined; the use of CLEC1B for identifying substances active in preventing and/or treating cardiovascular and/or thrombotic disorders and methods for doing so.
Abstract translation: 使用CLEC1B基因的单核苷酸多态性（SNP）来鉴定从被检查个体获取的生物样品中的心血管和/或血栓形成障碍或发生心血管和/或血栓形成障碍的风险增加; 使用CLEC1B来鉴别预防和/或治疗心血管和/或血栓形成障碍的物质及其方法。
-
-
-
-
-
-
-
-
-
Search Results
54
records
(took 0.019 seconds)
